A bimodal model of the mechanism of action of lithium

被引:70
作者
Jope, RS [1 ]
机构
[1] Univ Alabama, Dept Psychiat & Behav Neurobiol, Sparks Ctr 1057, Birmingham, AL 35294 USA
关键词
lithium; bipolar disorder; AP-1; cyclic AMP; valproate; carbamazepine;
D O I
10.1038/sj.mp.4000444
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Investigations of the biochemical actions of lithium have identified many individual reactions that are affected, especially within cellular signaling systems, but the actions of lithium at different sites often appear opposing and difficult to integrate into a general mechanism of action. A bimodal mechanism of action of lithium is proposed which is in accord with many of the apparently contradictory results that have been published. This model describes the critical effect of lithium as that of a stabilizer of the magnitude of fluctuations of signaling processes. This is achieved by lithium balancing positive and negative regulators of signaling processes which results in lithium raising basal activities and diminishing maximal activities, thereby stabilizing signaling activities within an optimal range and preventing fluctuations either above or below this optimum. This model is shown to be applicable to many published results concerning the activation of AP-1 DNA binding and cyclic AMP production. Diverse sites of action of lithium are proposed to ultimately converge on the regulation of gene expression to contribute to mood stabilization.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 35 条
[1]   Memory suppressor genes: Inhibitory constraints on the storage of long-term memory [J].
Abel, T ;
Martin, KC ;
Bartsch, D ;
Kandel, ER .
SCIENCE, 1998, 279 (5349) :338-341
[2]  
Atack JR, 1996, BRAIN RES REV, V22, P183
[3]   LITHIUM INHIBITS ADRENERGIC AND CHOLINERGIC INCREASES IN GTP BINDING IN RAT CORTEX [J].
AVISSAR, S ;
SCHREIBER, G ;
DANON, A ;
BELMAKER, RH .
NATURE, 1988, 331 (6155) :440-442
[4]  
Belmaker RH, 1996, ANNU REV MED, V47, P47
[5]  
Chen G, 1996, J NEUROCHEM, V67, P2079
[6]  
Chen G, 1997, NEUROPSYCHOPHARMACOL, V16, P238
[7]  
Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597
[8]  
ELKIS H, 1995, ARCH GEN PSYCHIAT, V52, P735
[9]  
GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151
[10]   LITHIUM ADMINISTRATION MODULATES PLATELET GI IN HUMANS [J].
HSIAO, JK ;
MANJI, HK ;
CHEN, G ;
BITRAN, JA ;
RISBY, ED ;
POTTER, WZ .
LIFE SCIENCES, 1992, 50 (03) :227-233